ABS38: Add-on omalizumab significantly improves quality of life in patients with severe persistent allergic (IgE-mediated) asthma

INTRODUCTION: Patients with severe persistent allergic asthma experience frequent serious exacerbations and daily symptoms that diminish health-related quality of life (QoL). AIMS AND OBJECTIVES: To evaluate effects on QoL of add-on omalizumab, an anti-IgE therapy. Subjects and method: A pooled anal...

Full description

Saved in:
Bibliographic Details
Published in:Prim Care Respir J
Main Authors: Price, D., Fox, H., Surrey, K., Reisner, C.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2006
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6730753/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2006.04.137
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items